Introduction: Multiple myeloma is caused by abnormal proliferation of plasma cells that affects more commonly African Americans. It classically presents with hypercalcemia, renal failure, anemia, and lytic bone lesions. The aim of this article is to present an unusual case of a 63-year-old African-American female with multiple myeloma who presented with worsening right-sided eye swelling for the past 3 weeks and to briefly review ophthalmologic manifestations of multiple myeloma. Case description: Our patient’s presentation was associated with a throbbing frontal headache, nasal congestion, malaise, and weight loss. Differential diagnosis on admission included giant cell arteritis, conjunctivitis, preseptal cellulitis, glaucoma, acute sinus...
A 52-year-old woman presented with a 1-year complaint of unexplained/undesired weight loss of 13 lbs...
Plasma cell neoplasia is a lymphoid neoplastic proliferation of B cells. This denomination encloses ...
Multiple myeloma (MM) therapy is evolving, and several new drugs are now available, extending patien...
Copyright © 2012 Mona Hassan et al. This is an open access article distributed under the Creative Co...
Extramedullary plasmacytoma is a rare complication from multiple myeloma. We report a 56-year-old la...
A patient with myeloma presenting as retro orbital mass and renal failure is described. Myeloma pati...
Introduction: Extramedullary plasmacytomas are present in 13% of multiple myeloma (MM) patients. Les...
Introduction: Multiple myeloma is the second most common hematologic cancer. It is characterized by ...
Multiple myeloma is a hematologic malignancy characterized by clonal proliferation of plasma cells. ...
Multiple myeloma (MM) is a malignant plasma cell dyscrasia typically confined to the bone marrow. Ex...
SUMMARY: Extramedullary hematopoiesis is a complication of a number of myeloproliferative disor-ders...
Introduction. Multiple myeloma is a hematological malignancy of older adults where there is an abnor...
Multiple myeloma (MM) is a systemic disease that is part of a spectrum of disorders ranging from mon...
Priyanka Sharma,1 Haifa A Madi,1 Richard Bonshek,2 Stephen J Morgan11Sunderland Eye Infirmary, Sunde...
Multiple myeloma (MM) is a plasma cell malignancy involving the bone marrow and is the second most c...
A 52-year-old woman presented with a 1-year complaint of unexplained/undesired weight loss of 13 lbs...
Plasma cell neoplasia is a lymphoid neoplastic proliferation of B cells. This denomination encloses ...
Multiple myeloma (MM) therapy is evolving, and several new drugs are now available, extending patien...
Copyright © 2012 Mona Hassan et al. This is an open access article distributed under the Creative Co...
Extramedullary plasmacytoma is a rare complication from multiple myeloma. We report a 56-year-old la...
A patient with myeloma presenting as retro orbital mass and renal failure is described. Myeloma pati...
Introduction: Extramedullary plasmacytomas are present in 13% of multiple myeloma (MM) patients. Les...
Introduction: Multiple myeloma is the second most common hematologic cancer. It is characterized by ...
Multiple myeloma is a hematologic malignancy characterized by clonal proliferation of plasma cells. ...
Multiple myeloma (MM) is a malignant plasma cell dyscrasia typically confined to the bone marrow. Ex...
SUMMARY: Extramedullary hematopoiesis is a complication of a number of myeloproliferative disor-ders...
Introduction. Multiple myeloma is a hematological malignancy of older adults where there is an abnor...
Multiple myeloma (MM) is a systemic disease that is part of a spectrum of disorders ranging from mon...
Priyanka Sharma,1 Haifa A Madi,1 Richard Bonshek,2 Stephen J Morgan11Sunderland Eye Infirmary, Sunde...
Multiple myeloma (MM) is a plasma cell malignancy involving the bone marrow and is the second most c...
A 52-year-old woman presented with a 1-year complaint of unexplained/undesired weight loss of 13 lbs...
Plasma cell neoplasia is a lymphoid neoplastic proliferation of B cells. This denomination encloses ...
Multiple myeloma (MM) therapy is evolving, and several new drugs are now available, extending patien...